Adverse health effects for individuals who move between HIV care centers

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 1, 2011, Pages 51-54

  Krentz, Hartmut B ^a,b   Worthington, Heather ^a   Gill, M John ^a,b  

^a Sheldon M Chumir Health Centre   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

adherence; Canada; continuity of care; HIV AIDS; lost to follow up; mobility; treatment interruptions; treatment outcomes

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH CENTER; HEALTH PROGRAM; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL;

ADULT; ALBERTA; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONTINUITY OF PATIENT CARE; DELIVERY OF HEALTH CARE; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS;

EID: 79955001997     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318214feee     Document Type: Article

References (16)

1. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N. Eng J Med. 2006;355:2283-2296.
2. The Antiretroviral Therapy (ART) Cohort Collaboration. Prognosis of HIV-1 infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS. 2007;21:1185-1197.
3. Egger M, May M, Chene G, et al. Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-129. (Pubitemid 34786200)
4. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378-384. (Pubitemid 41073955)
5. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIVon survival. N. Eng J Med. 2009; 360:1815-1826.
6. Chadborn TR, Delpech VC, Sabin CA, et al. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004) AIDS. 2006;20:2371-2379. (Pubitemid 44789540)
7. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: update of and responses to highly active antiretroviral therapy. AIDS. 2004;18:2145-2151. (Pubitemid 39463679)
8. Girardi E, Sabin CA, d'Armino Monforte A. Late diagnosis of HIV infection: epidemiological features, consequences, and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007; 46:S3-S8. (Pubitemid 47312320)
9. Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009;21: 284-293.
10. Lanoy E, Mary-Krause M, Tattevin P, et al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol. 2006;59: 829-835.
11. Ndiaye B, Ould-Kaci K, Bataille P, et al. Incidence rate and risk factors for loss to follow-up in five French clinical centres of HIV-infected patient in Northern France - January 1997 to December 2006. Antivir Ther 2009 14(4):567-575.
12. Mocroft A, Kirk O, Aldins P, et al. Loss to follow-up in an international, multicentre observational study. HIV Medicine 2008;9:261-269. (Pubitemid 351517272)
13. Ndiaye B, Ould-Kaci K, Salleron J, et al. Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. AIDS. 2009;23:1786-1789.
14. Gill MJ, Krentz HB Unappreciated epidemiology: the churn effect in a regional HIV care a programme. Int J STD AIDS. 2009;20:540-544.
15. Lima V, Fernandes K, Rachlis B, et al. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med. 2009;68:1044-1049.
16. Marks G, Gardner LI, Craw J, et al. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24: 2665-2678.